Tequin

Tequin®

Gatofloxacin Infectious disease A broad-spectrum quinolone used for UTIs and RTIs. See Fluoroquinolone.
Mentioned in ?
References in periodicals archive ?
A large phase IV post marketing trial with gatifloxacin (The Tequin Clinical Experience Study) reported an overall frequency of 0.
Winners for Davao City in judo were Andre Tequin (-55kg), James Ryan (-73kg) and Chino Tancontian (-50kg) for boys and Jhanen Marcos (-40kg), Sydney Tancontian (-70kg), Steffany Calamba (-44kg) and Charisse Aseneta (-52kg) for girls.
Bristol-Myers also offers Cefzil, Tequin, Maxipime and other antibiotics.
The rate of liver failure was calculated at 23/10 million prescriptions, much higher than for four other popular antibiotics, including Avelox (moxifloxacin), Tequin (gatifloxacin), Biaxin (clarithromycin), and Zithromax (azithromycin).
In 2007, seven popular products--Norvasc (amlodipine besylate), Ambien (zoldipem tartrate), Zyrtec (cetirizine), Lotrel (amlodipine/benazepril), Coreg (carvedilol), Lamisil (terbinafine), and Tequin (gatifloxicin), are due to lose patent protection, noted PCMA, which could lead to $700 million in savings that year.
cross] Diabetes and Tequin Don't Mix: Tequin--an antibiotic used to treat lung, sinus, and urinary tract infections along with same sexually transmitted diseases--affects blood sugar levels and should be avoided by people with diabetes.
has announced labeling changes for Tequin (gatifloxacin) that update the prescription information as a result of continued reports of cases of hypoglycemia and hyperglycemia in patients taking the drug.
Gatifloxacin, marketed by Bristol-Myers Squibb as Tequin, could receive a pediatric indication in early 2004.
While amoxicillin, trimethoprim/sulfamethoxazole (TMP/SMX) (Septra/Bactrim), erythromycin and doxycycline are still flrstline drugs for upper and lower respiratory tract infections, it is important to save Ceftin, Vantin, Spectracef, Avelox, Levaquin and Tequin for cases involving resistant pneumococcus, Moraxella catarrhalis and Haemophilus influenzae.
With the recent threat of anthrax and the potential loss of life, the company has announced several actions that will be taken in support of the campaign: 1) provide 20-25 fully-funded scientists specialized in anti-bacterial research to pursue research under government direction, 2) make the antibiotic Tequin (gatifloxacin) available at no cost to treat any person confirmed to have anthrax infection or as prophylaxis for someone who has been exposed to anthrax spores, and 3) consider sharing the Tequin license with the government in the event that demand exceeds supply.